In Vivo Toxicology Market Set to Reach USD 9.5 Billion by 2033

The latest report on the global in vivo toxicology market predicts substantial growth, with the market poised to exceed USD 9.5 billion by the end of the forecast period in 2033. The market, which was valued at USD 5.2 billion in 2022, is expected to witness a notable CAGR of 5.6% from 2023 to 2033.

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝 𝐟𝐨𝐫 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞) -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85513

Consumables to Drive Revenue Growth

Consumables are projected to be the highest revenue-generating segment in the in vivo toxicology market, with an anticipated CAGR of over 5% from 2023 to 2033. Consumables, including reagents, kits, and test systems, are critical components in in vivo toxicology testing, and their demand is expected to rise significantly due to the continuous development of new drugs in the pharmaceutical industry.

Key Drivers of Market Expansion

In vivo toxicology involves studying the potential toxicity of substances on living organisms, primarily animals. The key drivers influencing the expansion of the in vivo toxicology industry include:

Safety and Efficacy Testing Demand: The pharmaceutical and biotechnological industries are witnessing an increasing demand for safety and efficacy testing. The advancement in technologies, such as gene editing and gene therapy, necessitates specialized toxicology testing, driving the outsourced in vivo toxicology testing market.

Government Investments in Research: Government investments in research and development, especially in the United States, are propelling market growth. For instance, the NIH's National Institute of Environmental Health Sciences (NIEHS) invested over $78 million in toxicology-related research in 2021.

Role in COVID-19 Vaccine Development: In vivo toxicology testing played a crucial role in the development of COVID-19 vaccines and treatments. Animal models, especially mice, were utilized to test the safety and efficacy of vaccines and therapeutics before human trials, contributing to market growth.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=85513

Regional Highlights

North America: Dominating the market with a size of $2.1 billion in 2022, North America is expected to reach a market worth $3.9 billion by 2033. Increased investment in health research, especially related to gene editing technology, is a significant factor influencing the region's market growth.

United States: The U.S. in vivo toxicology market is projected to be worth $3.4 billion by 2033, growing at a CAGR of 5.4%. The increase in lung cancer cases has led to a demand for new drug discovery, driving the in vivo toxicology testing market.

United Kingdom, China, Japan, and India: These countries are also expected to contribute significantly to market growth, driven by factors such as research investments, disease prevalence, and drug development initiatives.

Key Players and Recent Developments

Key players in the in vivo toxicology market include Charles River Laboratories, THE JACKSON LABORATORY, Envigo, Taconic Biosciences, Inc., genOway, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, BioSpace, and Bio-Rad Laboratories. Recent developments include Charles River Laboratories' launch of a new testing platform for the detection of residual host cell DNA and Shimadzu's introduction of a new MALDI-TOF mass spectrometer.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030

This release was published on openPR.